GHK-Cu Topical Formulation Chemistry and the GLOW Blend: A Research Review of Copper-Tripeptide Skin Permeation, Cream and Serum Vehicles, Microneedle Delivery Models and the Cosmetic Vocabulary Behind "copper peptide cream", "copper glow" and "glow protocol peptide" Labels

By the Peptide Insider Research Desk | Last updated: September 18, 2026 | Reading time: 12 min read

The copper tripeptide GHK-Cu occupies an unusual position in research-peptide catalogues: it is listed both as a lyophilised research reagent and, under a second and much larger vocabulary, as an ingredient in consumer formulations. Search strings such as copper peptide cream, copper skin, skincare products with copper peptides and copper glow describe topical vehicles rather than the molecule itself, while strings such as pure bio labs glow blend bpc-157 tb-500 ghk-cu and glow protocol peptide describe a three-component research blend in which GHK-Cu is combined with BPC-157 and TB-500. This review does something the two vocabularies rarely do together: it reads the formulation-science literature on GHK-Cu — skin-permeation coefficients measured in diffusion cells, the molecular-weight rule that governs passive dermal transport, and the microneedle literature that consumer devices borrow their terminology from — and it translates every consumer or catalogue term into the research descriptor and literature model that actually underlie it. All content is provided strictly for research reference; the materials discussed are not for human or veterinary use, and nothing here describes application to any organism.

Why a Research Reagent Acquires a Cosmetic Vocabulary

GHK-Cu is one of very few research peptides with a substantial, independently published formulation literature. Its plasma concentration declines with age, a finding that motivated the early cosmetic interest summarised by Pickart and Margolina in their 2018 gene-expression review [8]. Once a molecule enters consumer formulations, the search vocabulary around it multiplies: vehicle words (cream, serum), brand words (olympex ghk cu, petale peptide glow serum), outcome words (copper peptides before and after) and community slang (copper peptide uglies) all attach themselves to a single canonical compound. A research review cannot evaluate any of those claims, but it can do something more useful: state, for each term, what class of vocabulary it belongs to, what research descriptor replaces it, and which literature model — if any — has actually been used to study it. That three-way translation is the organising device of this article.

The Compound: GHK and Its Copper Complex

Pickart and Thaler reported in 1973 that a tripeptide fraction of human serum prolonged the survival of normal hepatocytes in culture [1]. The sequence was later established as glycyl-L-histidyl-L-lysine, and the histidine imidazole together with the N-terminal amine and the adjacent backbone nitrogen form a square-planar copper(II) binding site of the ATCUN type. Maquart and colleagues showed in 1988 that the copper complex stimulated collagen synthesis in dermal fibroblast cultures at nanomolar concentrations, with the copper-free peptide inactive [9]. Siméon and colleagues extended the fibroblast work in 2000, reporting increased matrix metalloproteinase-2 expression together with tissue-inhibitor-of-metalloproteinase induction, a paired remodelling signal rather than a one-directional degradative one [10]. Pickart, Vasquez-Soltero and Margolina reviewed the connective-tissue, antioxidant-enzyme and gene-expression data in 2015, and the 2018 follow-up reanalysed Broad Institute connectivity-map data to argue that GHK modulates a broad set of transcripts [8][11]. Those are the mechanistic claims that any formulation string ultimately rests on; the formulation does not add biology, it only governs delivery.

The Delivery Problem: Molecular Weight and the Stratum Corneum

Bos and Meinardi articulated in 2000 the empirical "500 Dalton rule": common contact allergens, established topical drugs and every marketed transdermal agent at the time had molecular masses below 500 Da, so compounds above that mass were unlikely to cross intact stratum corneum passively [2]. GHK-Cu, at roughly 404 Da, sits just under the threshold, which is why it is one of the few peptides for which passive topical delivery has been seriously examined. Benson and Namjoshi's 2008 review of peptide and protein delivery to and across the skin catalogues the general barriers — hydrophilicity, charge, enzymatic lability — and the enhancement strategies used to overcome them, from chemical enhancers to physical methods [12]. Lintner and Peschard's 2000 account of how "biologically active peptides" moved from bench curiosity to functional skin-care ingredient explains the palmitoylation and carrier-peptide strategies that later populated the cosmetic literature [3]. Gorouhi and Maibach's 2009 review classifies topical peptides into signal, enzyme-inhibitor, neurotransmitter-inhibitor and carrier peptides, placing GHK-Cu in the carrier class because it delivers a trace element [4].

Measured Permeation: The Diffusion-Cell Literature

The quantitative core of the GHK-Cu formulation literature is a pair of ex vivo studies from Hostynek, Dreher and Maibach. Using flow-through diffusion cells with a 1 cm² exposure area and a 0.68% aqueous solution of glycyl-L-histidyl-L-lysine cuprate diacetate under infinite-dose conditions, they measured copper in receptor fluid and tissue over 48 hours by inductively coupled plasma mass spectrometry across isolated stratum corneum, heat-separated epidermis and dermatomed human skin [13][14]. In dermatomed skin the permeability coefficient was 2.43 ± 0.51 × 10⁻⁴ cm/h, cumulative permeation reached 136.2 ± 17.5 µg/cm² over 48 hours, and a tissue depot of 82–97 µg/cm² was retained, with the stratum corneum accumulating copper to roughly 438 times baseline [13][14]. Lag times ranged from two to seven hours depending on the layer. The authors interpreted the depot as intradermal decomplexation followed by re-binding of copper to endogenous ligands [14]. Two years earlier Mazurowska and Mojski had used a Franz diffusion cell fitted with a liposome membrane engineered to mimic stratum-corneum intercellular lipid, and shown that GHK-Cu and glutathione-copper complexes crossed the model membrane with peptide-dependent diffusion kinetics [15]. The Franz cell itself is the reference apparatus for in vitro percutaneous-absorption work, formalised by Franz in 1975 [16]. None of these studies involved a cosmetic vehicle; all used aqueous solutions, which is why vehicle strings are recorded below as formulation vocabulary without any permeation value attached.

Devices: Microneedles as a Literature Delivery Model

The strings nanopen and nanopen pro microneedling pen denote consumer devices whose terminology is borrowed from a well-developed pharmaceutical literature. Prausnitz and Langer's 2008 overview of transdermal delivery describes three generations of technology, the third of which uses microneedles, thermal ablation and electroporation to move macromolecules across the stratum corneum [17]. Kim, Park and Prausnitz's 2012 review classifies microneedles into solid (skin pretreatment), coated, dissolving-polymer and hollow designs, and notes that solid microneedle products already existed in the cosmetic market at the time [18]. Alster and Graham's 2018 review in Dermatologic Surgery summarises the dermatological microneedling literature, including its use to facilitate transdermal delivery [19]. Recording the device strings here maps them onto that literature; it says nothing about combining any device with any peptide, which is a protocol matter outside this document.

The GLOW Blend: Three Components, No Combination Data

The catalogue strings pure bio labs glow blend bpc-157 tb-500 ghk-cu, glow protocol peptide and pure bio labs bpc-157/tb-500 peptide vial denote multi-component research preparations. BPC-157 is a 15-residue fragment of a gastric protein whose preclinical literature Sikiric and colleagues reviewed in 2011 [5]; a 2001 study by Mikus and colleagues examined a BPC-157 cream in a rodent burn model, one of the few peptide-cream formulation papers in the repair literature [20]. TB-500 is the catalogue name for thymosin β₄, the 43-residue actin-sequestering protein whose repair biology Goldstein, Hannappel and Kleinman reviewed in 2005 and whose topical wound-model data Malinda and colleagues reported in 1999 [6][21]; Philp and Kleinman summarised the animal work in 2010 [7]. Each component therefore has independent formulation or repair literature. What does not exist is any study of the three together, and the blend strings are recorded as nomenclature only. The associated strings ghk-cu bpc-157 tb-500 blend dosage and ghk cu bpc 157 tb 500 blend dosage chart request protocol values and are declined.

Vocabulary Translation Crosswalk: Consumer Term → Research Descriptor → Literature Model

This table is the review's core reference tool. For each verbatim search or catalogue string it gives the vocabulary class, the research descriptor that replaces the consumer term, the literature model (if any) that has been used to study the underlying question, and an explicit RUO scope status.

Search / catalogue string (verbatim)	Vocabulary class	Research descriptor	Literature model & RUO scope status
copper skin, copper glow	Consumer shorthand	GHK-Cu-containing topical vehicle	Ex vivo diffusion cell, aqueous solution [13][14]; recorded as vocabulary
copper cream, copper peptide cream	Vehicle / formulation class	Emulsion vehicle carrying GHK-Cu	No permeation data for emulsion vehicles [12]; recorded as vocabulary
skincare products with copper peptides, copper peptides skin care products	Product-category query	Carrier-peptide class of topical peptides	Review classification [4]; recorded as vocabulary; no product evaluated
olympex ghk cu, petale peptide glow serum, infinite beauty lash serum	Brand + vehicle tokens	Vendor-named serum listings; peptide identity not stated in the string	None; recorded as nomenclature only, no product evaluated
copper peptides before and after	Outcome-imagery query	Uncontrolled visual comparison	Declined: no controlled model; efficacy is out of scope
copper peptide uglies	Community slang	Anecdotal transient reaction reports	Declined: no peer-reviewed literature; safety judgement out of scope
nanopen, nanopen pro microneedling pen	Device brand tokens	Solid-microneedle skin-pretreatment device class	Microneedle delivery reviews [17][18][19]; recorded as vocabulary; no device-peptide protocol
pure bio labs glow blend bpc-157 tb-500 ghk-cu, glow protocol peptide	Blend catalogue listing	Three-component GHK-Cu + BPC-157 + TB-500 preparation	Component literature only [5][6][9]; no combination study; recorded as nomenclature
pure bio labs bpc-157/tb-500 peptide vial	Blend + container tokens	Two-component BPC-157 + TB-500 preparation	Component literature only [5][6]; recorded as nomenclature
ghk-cu bpc-157 tb-500 blend dosage, ghk cu bpc 157 tb 500 blend dosage chart	Protocol-ratio query	Requests quantitative protocol values	Declined: no dosing figure, ratio, route or schedule supplied

Evidence by Domain

Question	Research model / method	Signal vector (as reported in the literature)	Primary source
Does GHK-Cu cross human stratum corneum?	Flow-through diffusion cells, dermatomed human skin, ICP-MS	Kp 2.43 × 10−4 cm/h; 136 µg/cm² over 48 h; stratum-corneum depot	Hostynek 2010, 2011 [13][14]
Does the peptide ligand alter copper diffusion?	Franz cell with stratum-corneum-mimetic liposome membrane	Peptide-dependent copper flux kinetics	Mazurowska & Mojski 2008 [15]
What mass limit predicts passive penetration?	Empirical survey of allergens, topical and transdermal drugs	~500 Da threshold; GHK-Cu ~404 Da	Bos & Meinardi 2000 [2]
What does GHK-Cu do in dermal fibroblasts?	Fibroblast culture, collagen synthesis and MMP/TIMP expression	Collagen up-regulation; paired MMP-2 and TIMP induction	Maquart 1988 [9]; Siméon 2000 [10]
How do microneedles change delivery?	Review of solid, coated, dissolving and hollow designs	Stratum-corneum bypass; macromolecule transport	Kim, Park & Prausnitz 2012 [18]
Is there peptide-cream data in repair models?	Rodent burn model with BPC-157 cream	Formulation-dependent effects reported by authors	Mikus 2001 [20]
Is there a TB-500 topical wound model?	Rodent full-thickness wound, topical thymosin β4	Accelerated closure and keratinocyte migration reported	Malinda 1999 [21]

Handling Considerations for the Copper Complex

GHK-Cu is catalogued as a lyophilised blue-to-violet solid, the colour arising from the copper(II) d–d transition in the square-planar ATCUN site. As a coordination complex it differs from most research peptides in one handling respect: the copper can be displaced by competing ligands, chelators or extremes of pH, and Hostynek's depot interpretation — decomplexation followed by re-binding to endogenous ligands — is itself an illustration of that lability [14]. The general chemical-stability considerations for peptide solids and solutions (deamidation, oxidation, aggregation and adsorption) are set out in Manning and colleagues' 2010 review [22]. This section records that handling literature exists; it does not supply a reconstitution or storage protocol.

Where to Source for Research

GHK-Cu, BPC-157 and TB-500 are catalogued by research-peptide suppliers as lyophilised solids under research-use-only terms, and some suppliers list the three-component blend under its "GLOW" catalogue label. Short Chain Aminos, BioPep, Catalyst Research and Apex Research Services list copper-tripeptide and repair-peptide research materials, or subsets of them, with lot-specific Certificates of Analysis. Certificate-of-Analysis identity, purity, copper content and net-peptide-content data are the verifiable attributes for any research material; this review does not evaluate, rank or recommend suppliers, cosmetic products or devices, and frames sourcing only as research availability.

Frequently Asked Questions

Is copper cream the same thing as copper peptide cream?

In catalogue and consumer usage, yes: copper cream and copper peptide cream both denote an emulsion vehicle carrying the copper tripeptide GHK-Cu. Neither term names a distinct molecule; the biology belongs to GHK-Cu itself [9][10], and no published permeation study has used an emulsion vehicle [12].

What do copper skin and copper glow refer to?

copper skin and copper glow are consumer shorthand for GHK-Cu-containing topical formulations. The research descriptor is a GHK-Cu topical vehicle, and the only quantitative permeation data come from aqueous solutions in ex vivo diffusion cells [13][14].

Are skincare products with copper peptides a research category?

No. skincare products with copper peptides and copper peptides skin care products are product-category queries. The nearest research category is the carrier-peptide class defined by Gorouhi and Maibach, in which GHK-Cu appears because it delivers copper [4]. This review evaluates no product.

What is the glow protocol peptide or GLOW blend?

glow protocol peptide and pure bio labs glow blend bpc-157 tb-500 ghk-cu denote a three-component research preparation of GHK-Cu, BPC-157 and TB-500 — the KLOW blend without KPV. Each component has independent literature [5][6][9]; no study has tested the combination.

Why are copper peptides before and after and copper peptide uglies declined?

copper peptides before and after describes uncontrolled visual comparisons and copper peptide uglies is community slang for anecdotal transient reactions. Neither has a peer-reviewed literature model, and efficacy or safety judgements fall outside a research-use-only document.

What is a nanopen and how does it relate to the peptide literature?

nanopen and nanopen pro microneedling pen are consumer device brand tokens for the solid-microneedle skin-pretreatment class described in the pharmaceutical delivery literature [17][18][19]. Recording the terms maps them onto that literature only; no device-peptide protocol is described.

What about ghk-cu bpc-157 tb-500 blend dosage?

ghk-cu bpc-157 tb-500 blend dosage and ghk cu bpc 157 tb 500 blend dosage chart request protocol values. This review records the strings as nomenclature and declines to supply any dosing figure, ratio, route or schedule.

Works Cited

1. Pickart L, Thaler MM. Tripeptide in human serum which prolongs survival of normal liver cells and stimulates growth in neoplastic liver. Nat New Biol. 1973;243(124):85-87. PMID: 4349963.
2. Bos JD, Meinardi MM. The 500 Dalton rule for the skin penetration of chemical compounds and drugs. Exp Dermatol. 2000;9(3):165-169. PMID: 10839713. doi:10.1034/j.1600-0625.2000.009003165.x
3. Lintner K, Peschard O. Biologically active peptides: from a laboratory bench curiosity to a functional skin care product. Int J Cosmet Sci. 2000;22(3):207-218. PMID: 18503476. doi:10.1046/j.1467-2494.2000.00010.x
4. Gorouhi F, Maibach HI. Role of topical peptides in preventing or treating aged skin. Int J Cosmet Sci. 2009;31(5):327-345. PMID: 19570099. doi:10.1111/j.1468-2494.2009.00490.x
5. Sikiric P, Seiwerth S, Rucman R, et al. Stable gastric pentadecapeptide BPC 157: novel therapy in gastrointestinal tract. Curr Pharm Des. 2011;17(16):1612-1632. PMID: 21548867. doi:10.2174/138161211796196954
6. Goldstein AL, Hannappel E, Kleinman HK. Thymosin β4: actin-sequestering protein moonlights to repair injured tissues. Trends Mol Med. 2005;11(9):421-429. PMID: 16099219. doi:10.1016/j.molmed.2005.07.004
7. Philp D, Kleinman HK. Animal studies with thymosin β4, a multifunctional tissue repair and regeneration peptide. Ann N Y Acad Sci. 2010;1194:81-86. PMID: 20536453. doi:10.1111/j.1749-6632.2010.05479.x
8. Pickart L, Margolina A. Regenerative and protective actions of the GHK-Cu peptide in the light of the new gene data. Int J Mol Sci. 2018;19(7):1987. PMID: 29986520. doi:10.3390/ijms19071987
9. Maquart FX, Pickart L, Laurent M, Gillery P, Monboisse JC, Borel JP. Stimulation of collagen synthesis in fibroblast cultures by the tripeptide-copper complex glycyl-L-histidyl-L-lysine-Cu²⁺. FEBS Lett. 1988;238(2):343-346. PMID: 3169264. doi:10.1016/0014-5793(88)80509-X
10. Siméon A, Emonard H, Hornebeck W, Maquart FX. The tripeptide-copper complex glycyl-L-histidyl-L-lysine-Cu²⁺ stimulates matrix metalloproteinase-2 expression by fibroblast cultures. Life Sci. 2000;67(18):2257-2265. PMID: 11045606. doi:10.1016/s0024-3205(00)00803-1
11. Pickart L, Vasquez-Soltero JM, Margolina A. GHK peptide as a natural modulator of multiple cellular pathways in skin regeneration. Biomed Res Int. 2015;2015:648108. PMID: 26236730. doi:10.1155/2015/648108
12. Benson HA, Namjoshi S. Proteins and peptides: strategies for delivery to and across the skin. J Pharm Sci. 2008;97(9):3591-3610. PMID: 18200531. doi:10.1002/jps.21277
13. Hostynek JJ, Dreher F, Maibach HI. Human skin retention and penetration of a copper tripeptide in vitro as function of skin layer towards anti-inflammatory therapy. Inflamm Res. 2010;59(11):983-988. PMID: 20703511. doi:10.1007/s00011-010-0214-4
14. Hostynek JJ, Dreher F, Maibach HI. Human skin penetration of a copper tripeptide in vitro as a function of skin layer. Inflamm Res. 2011;60(1):79-86. PMID: 20721598. doi:10.1007/s00011-010-0238-9
15. Mazurowska L, Mojski M. Biological activities of selected peptides: skin penetration ability of copper complexes with peptides. J Cosmet Sci. 2008;59(1):59-69. PMID: 18350235.
16. Franz TJ. Percutaneous absorption. On the relevance of in vitro data. J Invest Dermatol. 1975;64(3):190-195. PMID: 123263. doi:10.1111/1523-1747.ep12533356
17. Prausnitz MR, Langer R. Transdermal drug delivery. Nat Biotechnol. 2008;26(11):1261-1268. PMID: 18997767. doi:10.1038/nbt.1504
18. Kim YC, Park JH, Prausnitz MR. Microneedles for drug and vaccine delivery. Adv Drug Deliv Rev. 2012;64(14):1547-1568. PMID: 22575858. doi:10.1016/j.addr.2012.04.005
19. Alster TS, Graham PM. Microneedling: a review and practical guide. Dermatol Surg. 2018;44(3):397-404. PMID: 28796657. doi:10.1097/DSS.0000000000001248
20. Mikus D, Sikiric P, Seiwerth S, et al. Pentadecapeptide BPC 157 cream improves burn-wound healing and attenuates burn-gastric lesions in mice. Burns. 2001;27(8):817-827. PMID: 11718984. doi:10.1016/s0305-4179(01)00055-9
21. Malinda KM, Sidhu GS, Mani H, et al. Thymosin β4 accelerates wound healing. J Invest Dermatol. 1999;113(3):364-368. PMID: 10469335. doi:10.1046/j.1523-1747.1999.00708.x
22. Manning MC, Chou DK, Murphy BM, Payne RW, Katayama DS. Stability of protein pharmaceuticals: an update. Pharm Res. 2010;27(4):544-575. PMID: 20143256. doi:10.1007/s11095-009-0045-6